title: The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems.  Are there any new Parkinson's drugs which are safer for patients with heart risks?
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001022:Aortic Valve Insufficiency / Q000139:chemically induced / Q000517:prevention & control*; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D004873:Ergolines / Q000008:administration & dosage / Q000009:adverse effects*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D004873:Ergolines; D010479:Pergolide; D000077465:Cabergoline